Filing Flows › Covista (CVSA) › Q1 FY27 › vs Q1 FY26
Covista (CVSA) Q1 FY27 vs Q1 FY26 (year over year)
Covista's revenue rose $49.2M (+11%) from $462M in Q1 FY26 to $512M in Q1 FY27. The biggest changes: Walden +$26.7M (+14%); Chamberlain +$13.2M (+7%); Medical and Veterinary +$9.3M (+10%). Operating margin 19.2% against 18.5% (+0.7 pts).
Covista, Q1 FY27: revenue $512M (+11% year over year), operating margin 19.2%, net earnings $67.4M, operating cash flow $114M. The chart draws each line against Q1 FY26, the increases inside each band.
Margins
| Q1 FY27 | Q1 FY26 | Change | |
|---|---|---|---|
| Operating margin | 19.2% | 18.5% | +0.7 pts |
| Net margin | 13.2% | 13.4% | -0.2 pts |
| Free cash flow margin | 14.9% | 24.8% | -9.8 pts |
Every line
| Line | Q1 FY27 | Q1 FY26 | Change | % |
|---|---|---|---|---|
| Walden | $217M | $190M | $26.7M | +14% |
| Chamberlain | $192M | $179M | $13.2M | +7% |
| Medical and Veterinary | $102M | $93.1M | $9.3M | +10% |
| Revenue | $512M | $462M | $49.2M | +11% |
| Operating profit | $98.0M | $85.5M | $12.6M | +15% |
| Costs & expenses | $414M | $377M | $36.7M | +10% |
| Pre-tax earnings | $85.4M | $77.6M | $7.8M | +10% |
| Other expense, net | $12.6M | $7.8M | $4.7M | +61% |
| Cost of revenue | $221M | $201M | $20.0M | +10% |
| SG&A | $193M | $176M | $16.9M | +10% |
| Net earnings | $67.4M | $61.8M | $5.6M | +9% |
| Income tax | $18.0M | $15.8M | $2.2M | +14% |
| Depreciation & amortization | $12.3M | $13.1M | −$845K | -6% |
| Share-based compensation | $8.2M | $8.3M | −$112K | -1% |
| Working capital & other | $26.2M | $47.3M | −$21.1M | -45% |
| Operating cash flow | $114M | $131M | −$16.5M | -13% |
| Free cash flow (OCF − capex) | $76.4M | $115M | −$38.1M | -33% |
| Capital expenditures | $37.6M | $16.0M | $21.6M | +135% |
Questions
How much did Covista's revenue grow year over year in Q1 FY27?
Covista's revenue rose $49.2M (+11%) from $462M in Q1 FY26 to $512M in Q1 FY27.
What drove Covista's revenue change in Q1 FY27?
Walden +$26.7M (+14%); Chamberlain +$13.2M (+7%); Medical and Veterinary +$9.3M (+10%).